Clozapine clinics at the crossroads and the opportunity to redesign services for people with chronic schizophrenia.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41410072.
- Also identified by DOI 10.1192/bjp.2025.10513.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Forthcoming changes to clozapine monitoring present an opportunity to expand, not dilute, specialist care for chronic schizophrenia. Reduced administrative burden should support timely clozapine use, structured assessment, access to psychological therapies and embedded physical health care. Experience from Cambridgeshire shows that secondary-plus clinics within community mental health teams can deliver sustained, equitable long-term care.
Medical subject headings
- Antipsychotic Agents
- Clozapine
- Community Mental Health Services
- Schizophrenia